Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of AMW goserelin 3.6 mg implant in prostate cancer
2014-002484-15Phase 3Completed
- Sponsor
- AMW GmbH
- Start
- Sep 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of goserelin in prostate cancer (PCa), sponsored by AMW GmbH. Started Sep 2015; status: completed.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2014-002484-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002484-15.